Cantor Fitzgerald Raises PT on Palantir Technologies Inc. (PLTR) Following Record-Breaking Q2 2025 Results

Cantor Fitzgerald raised its price target on Palantir Technologies (PLTR) to $155 from $110, maintaining a 'Neutral' stance, following the company's record-breaking Q2 2025 results. This performance was driven by the U.S. Commercial segment exceeding Street estimates by 15%, supporting management's projected sustained 90% growth and an increased U.S. revenue focus, expected to comprise nearly 80% of revenue by 2026. Palantir also achieved a 'Rule of 94' in Q2 with record contract value bookings, guiding for 'Rule of 95' in Q3, despite a second consecutive quarter of slipping international commercial revenue.

Analysis

Cantor Fitzgerald has raised its price target on Palantir Technologies (PLTR) to $155 from $110 while notably maintaining a 'Neutral' rating, signaling confidence in valuation but caution on further upside. The upward revision is directly tied to record-breaking Q2 2025 results, primarily fueled by the U.S. Commercial segment which surpassed Street estimates by a substantial 15%. Management's projection of sustained 90% growth in this area, coupled with record contract value bookings, underpins the positive outlook. The company's performance is further quantified by its achievement of a "Rule of 94" (combining revenue growth and profitability) in Q2, with strong guidance for a "Rule of 95" in Q3 and "Rule of 91" for the full year. However, this domestic strength is contrasted by a significant headwind: international commercial revenue has now declined for two consecutive quarters. This underperformance is leading to a strategic pivot, with the company's revenue base becoming increasingly concentrated in the U.S., which is now expected to comprise nearly 80% of total revenue by 2026.

Key Decisions for Investors

• Investors should weigh the exceptional 15% revenue beat and 90% growth projection in the U.S. Commercial segment against the clear risk of a second consecutive quarterly decline in international revenue.
• The combination of a significant price target increase to $155 with a maintained 'Neutral' rating suggests the analyst sees the stock as fairly valued, with the strong domestic performance already priced in.
• Monitor future earnings for any stabilization or recovery in the international segment, as a turnaround could be a catalyst for a ratings upgrade, while continued U.S. revenue concentration above 80% heightens single-market risk.